Home › Interstitial Lung Diseases › Massachusetts
Interstitial Lung Diseases clinical trials in Massachusetts
12 studies for Interstitial Lung Diseases are looking for participants at sites in Massachusetts.
Cities in Massachusetts
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Tufts Medical Center, Boston
- Brigham and Women's Hospital, Boston
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 29, 2026 · NCT05798923A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06806592A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- Brigham and Women's Hospital, Boston
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 8, 2026 · NCT07201922Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Brigham and Women's Hospital, Boston
Recruiting
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06911632A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Boston
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Sep 2, 2026 · NCT07333183Platform Clinical Study for Conquering Scleroderma
- Massachusetts General Hospital, Boston
- Boston University (BU), Boston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06195072PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
- University of Massachusetts Chan Medical School, Worcester
RecruitingObservational study
Ages 18 to 80 · All sexes · Updated Aug 18, 2026 · NCT06855329Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
- Lahey Hospital and Medical Center, Burlington
RecruitingPhase 2
Ages 4 and older · All sexes · Updated Jul 22, 2026 · NCT04925375Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis
- Massachusetts General Hospital, Boston
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Jul 14, 2026 · NCT07572383Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
- Infinity Medical Center, North Dartmouth
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT05943535TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- Dana-Farber Cancer Institute/Boston Children's Hospital, Boston
RecruitingObservational study
Up to age 24 · All sexes · Updated Jun 22, 2026 · NCT04098445Collagen-targeted PET Imaging for Early Interstitial Lung Disease
- Massachusetts General Hospital, Boston
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Apr 20, 2026 · NCT05417776From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.